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httpsWHAT THIS PAPER ADDS
The mid-term re-intervention rate after ruptured abdominal aortic aneurysm repair by endovascular or open
repair appears to be twice as high as after elective repair. This suggests the need for bespoke surveillance
protocols after rupture. Limb ischaemia is a frequent early reason and distal aneurysms a frequent later reason
for re-intervention to indicate where quality improvement programmes might be directed. Limb amputation is
uncommon but higher after open repair than after endovascular aneurysm repair.Objective/Background: The aim was to describe the re-interventions after endovascular and open repair of
rupture, and investigate whether these were associated with aortic morphology.
Methods: In total, 502 patients from the IMPROVE randomised trial (ISRCTN48334791) with repair of rupture
were followed-up for re-interventions for at least 3 years. Pre-operative aortic morphology was assessed in a core
laboratory. Re-interventions were described by time (0e90 days, 3 monthse3 years) as arterial or laparotomy
related, respectively, and ranked for severity by surgeons and patients separately. Rare re-interventions to 1 year,
were summarised across three ruptured abdominal aortic aneurysm trials (IMPROVE, AJAX, and ECAR) and odds
ratios (OR) describing differences were pooled via meta-analysis.
Results: Re-interventions were most common in the ﬁrst 90 days. Overall rates were 186 and 226 per 100 person
years for the endovascular strategy and open repair groups, respectively (p ¼ .20) but between 3 months and 3
years (mid-term) the rates had slowed to 9.5 and 6.0 re-interventions per 100 person years, respectively
(p ¼ .090) and about one third of these were for a life threatening condition. In this latter, mid-term period, 42 of
313 remaining patients (13%) required at least one re-intervention, most commonly for endoleak or other
endograft complication after treatment by endovascular aneurysm repair (EVAR) (21 of 38 re-interventions),
whereas distal aneurysms were the commonest reason (four of 23) for re-interventions after treatment by open
repair. Arterial re-interventions within 3 years were associated with increasing common iliac artery diameter (OR
1.48, 95% conﬁdence interval [CI] 0.13e0.93; p ¼ .004). Amputation, rare but ranked as the worst re-
intervention by patients, was less common in the ﬁrst year after treatment with EVAR (OR 0.2, 95% CI 0.05e0.88)
from meta-analysis of three trials.
Conclusion: The rate of mid-term re-interventions after rupture is high, more than double that after elective
EVAR and open repair, suggesting the need for bespoke surveillance protocols. Amputations are much less
common in patients treated by EVAR than in those treated by open repair.
 2018 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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As experience with elective endovascular aneurysm repair
(EVAR) of abdominal aortic aneurysm (AAA) has increased
and stent graft technology has advanced, the rate of re-
interventions has reduced. In the early randomised trials,
the mid-term re-intervention rates were about 3.5 per 100
person years versus 0.5 per 100 person years after open
repair,1 but, today, much lower rates are reported from
more recent data.2 Endovascular repair of ruptured AAA
626 Janet T. Powell et al.presents additional challenges: the aneurysms are larger,
the emergency imaging may not be optimal, sizing for
endografts may be difﬁcult owing to hypotensive arterial
collapse, the available stock of endografts may be limited
and these may be used outside conservative instructions for
use (IFU). Therefore, there is widespread acceptance that
EVAR for rupture is likely to be associated with a higher re-
intervention rate than EVAR for elective repair.
There are few studies that report mid-term re-interven-
tion rates after either EVAR or open repair for rupture. The
most comprehensive study comes from the 467 patients
with repair of ruptured AAA in the Amsterdam cohort from
2004 to 2011.3 By 5 years 45% of the EVAR patients and
40% of the open repair patients had had at least one re-
intervention. The re-interventions in the primary admis-
sion and after discharge were described separately. After
discharge the rate of re-interventions after EVAR was nearly
four times as high as after open repair and a common
reason for re-intervention after EVAR was life threatening
graft infection.
The IMPROVE trial, which randomised 613 patients with a
clinical diagnosis of ruptured AAA to either an endovascular
strategy (EVAR if morphologically feasible, open repair if not)
or open repair, included 502 patients in whom repair of
rupture was commenced, and followed these patients for re-
interventions for 3 or more years. It has already been re-
ported that the overall re-intervention rates were not
signiﬁcantly different between the randomised groups and
that any additional re-interventions incurred in the endo-
vascular strategy group did not compromise the overall cost-
effectiveness of the endovascular strategy.4 The purpose
here is threefold: (i) to provide further insight concerning the
reasons for and rates of re-intervention (directly aneurysm
related and other) in the 502 patients with repair of rupture
started, both by randomised group and by treatment
received; (ii) to investigate whether pre-operative aneurysm
morphology was associated with re-intervention rates; and
(iii) to assess whether major amputation (an uncommon
outcome but one much feared by patients) was more
common after either EVAR or open repair in an individual
patient meta-analysis across the three recent European
randomised trials for the management of ruptured AAA.5e7
The ﬁrst two aims will also provide important information as
to whether surveillance protocols after rupture might need
to be different from those after elective AAA repair.METHODS
The design and patients of the IMPROVE trial
(ISRCTN48334791), their follow-up, and assessment of base-
line aortic morphology have been described previously.8,9
Brieﬂy, 613 patients with an in hospital clinical diagnosis of
ruptured AAA were randomised to either an endovascular
strategy (immediate computed tomography [CT] scan and
EVAR if morphologically feasible, otherwise open repair) or to
open repair (CT scan optional). Of these, 502 patients with a
conﬁrmed diagnosis of rupture had aneurysm repair or star-
ted aneurysm repair and were followed up by trained localcoordinators, for all re-interventions in the ﬁrst 30 days, and
aneurysm related re-interventions for 3 years thereafter. The
trial protocol required clinical follow-up with imaging at 3, 12,
and 36 months after repair, with intermediate follow-up left
to the discretion of each trial centre. A standardised protocol
for the detection and management of abdominal compart-
ment syndrome, with recording of intra-abdominal pressures,
was recommended but not widely followed. The complete-
ness of re-intervention data, including re-interventions at
non-trial hospitals, was veriﬁed by cross-checking against an
administrative data set for English patients (Hospital Episode
Statistics) and by detailed audit for Scottish and Canadian
patients. Re-interventions beyond 3 years were not collected
comprehensively. Re-interventions for pre-existing condi-
tions, for example colon cancer, which had been included for
the analysis of outcomes at 30 days are excluded from the
present analysis, whereas ﬁstula formation to treat renal
failure and endovascular treatment of pulmonary embolism
are included.Trial investigators extended the categorisation of
re-interventions used by the EVAR-1 trial to obtain a
consensus as to whether a re-intervention was for a life
threatening condition (Table S1 [see Supplementary
Material], with a full list of re-interventions).1 Two ob-
servers categorised the re-interventions as arterial, laparot-
omy related, or other, with differences resolved by discussion.
Separately, six patients or their spouses, from outside the
trial, were asked to rank the main re-interventions: they were
unanimous in reporting amputation of the leg as the most
feared re-intervention, followed by graft infection.
The indications for re-intervention are tabulated both by
randomised group and by treatment received. When two
separate indications for re-interventionwere corrected in the
same operating or endovascular session these are listed
separately but described in table footnotes.Multiple planned
recurring procedures requiring time in the operating theatre
(e.g., debridement, change of dressings) are excluded from
the descriptive tables (e.g., there would be only a single
listing for change of negative pressure wound therapy dres-
sing, even if this occurred on several occasions).
CT scans were acquired in DICOM format from hospital
archives, anonymised, and transferred to the core labora-
tory at St George’s Vascular Institute for three dimensional
reconstruction and analysis10; in total, 458 admission scans
from patients with conﬁrmed rupture were available.11 Five
morphological parameters (aortic diameter at 1 mm distal
to the distal renal artery, aneurysm neck length from distal
renal artery to sac, proximal neck angle a, maximum
aneurysm diameter, and maximum common iliac diameter)
were measured in a core laboratory and a sixth, neck con-
icality derived, as described previously.11 From these pa-
rameters the endovascular repairs were categorised as
either within liberal IFU or not (liberal IFU aneurysm neck
length  10 mm, neck diameter  32 mm, and neck
angle < 60).12 The 3 month follow up CT scans also were
collected in the core laboratory and were used to conﬁrm
the diagnosis of any underlying conditions requiring re-
intervention at this time. Individual patient data for base-
line characteristics and follow-up to 1 year were also
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European trials for ruptured AAA, AJAX and ECAR.13,14
Ethical approval for the IMPROVE trial was from South-
Central Berkshire Research Ethics Committee 08/H0505/
173 (England and Wales), Scotland A Research Ethics
Committee 08/MRE00/90 (Scotland), and the University of
Western Ontario Health Sciences Research Ethics Board
17698 (Canada).Statistical analyses
The analyses were conducted according to pre-speciﬁed
analysis plans. Rates of re-intervention were analysed on
an intention to treat basis and were not adjusted for
baseline variables. As previously, missing data for baseline
variables were imputed before analysis using chained
equations.15
For the analyses of associations with morphological pa-
rameters, Cox regression multiple failure time models were
ﬁtted adjusting for pre-speciﬁed confounders (age, sex,
Hardman index lowest recorded systolic blood pressure,
randomised group, and treatment commenced).16,17 A
further model additionally adjusted the estimates for the
effect of all the other morphological variables. For the IFU
analysis, hazard ratios, 95% conﬁdence intervals (CIs) and p
values (calculated using Wald’s test) are presented. Each of
the six morphological variables were considered as contin-
uous covariates and odds ratios (ORs) are reported based
on a 1 SD increase to allow fair comparison of their relative
importance.
For the meta-analysis of amputations in AJAX, ECAR, and
IMPROVE, primary analyses considered amputation ac-
cording to the groups “as randomised” within each trial,
irrespective of the different trial designs and secondary
analyses considered amputation following treatment
received. The timing of amputation was assessed from
randomisation (for IMPROVE) and from hospital admission
(for AJAX and ECAR). The OR of amputation for endovas-
cular repair (or endovascular strategy) versus open repair
for each trial was estimated and together were pooled us-
ing ﬁxed effect meta-analysis using a continuity correction
of ½ to trials with zero events. The proportion of between
trial variability beyond that expected by chance was quan-
tiﬁed using the I2 statistic.18
All analyses were conducted using Stata statistical soft-
ware, version 12 (StataCorp., College Station, TX, USA).
RESULTS
Of the 502 patients with repair of rupture started 259 had
been randomised to an endovascular strategy and 243 to
open repair; 182 patients commenced EVAR and 320
commenced open repair. The two groups were well
matched for baseline characteristics.4 The endovascular
strategy group had a mean age of 76.0 years, 50 were
women and the mean AAA diameter was 8.7 cm: 75 (29%)
required at least one re-intervention. The open repair group
had a mean age of 76.2 years, 48 were women, and the
mean AAA diameter was 8.4 cm: 66 (27%) required at leastone re-intervention. The overall re-intervention rates were
similar in the endovascular strategy and open repair groups
at 26.0 and 28.4 re-interventions per 100 person years,
respectively (p ¼ .52). Similarly, the overall rate of re-
interventions for life threatening conditions was similar
between the two groups at nine and 11 re-interventions per
100 person years, respectively (p ¼ .29).
The listing of indications for re-intervention are shown
separately for the acute period (0e90 days), the mid-term
(3 monthse3 years), and available information for beyond
3 years in Tables 1e3, respectively, both by randomised
group and by treatment received.
Re-interventions in the ﬁrst 90 days
In the ﬁrst 90 days, the re-intervention rates were high at
186 and 226 per 100 person years for the endovascular
strategy and open repair randomised groups, respectively
(p ¼ .20). Re-interventions for life threatening conditions
were slightly, but not signiﬁcantly, more common in both
those randomised to open repair and those treated by open
repair. The commonest indications for re-intervention were
bowel ischaemia and limb ischaemia, both of which were
more common in patients who received open repair. After
initial resolution of abdominal compartment syndrome,
later resection for bowel ischaemia occurred in three pa-
tients (two EVAR, one open repair). There were only two
cases of graft infection, both in the femoro-femoral cross-
over graft after treatment with an aorto-uni-iliac endograft.
Although AAA related deaths occurred throughout follow-
up, after the ﬁrst 30 days, none of these deaths occurred
within 30 days of a re-intervention.
Re-interventions between 3 months and 3 years following
repair
After 90 days 313/502 (62%) patients with repairs started
remained alive. In the endovascular strategy group, be-
tween 3 months and 3 years (mid-term), the re-intervention
rate decreased from 186 per 100 person years in the ﬁrst 90
days to 9.5 per 100 person years in the mid-term (hazard
ratio [HR] 0.05, 95% CI 0.04e0.07; p < .001). In the open
repair group, the rate decreased from 226 per 100 person
years in the ﬁrst 90 days to 6.0 per 100 person years in the
mid-term (HR 0.03, 95% CI 0.02e0.04; p < .001). In the
mid-term, the re-intervention rate for life threatening con-
ditions was 3.3 and 2.3 per 100 person years, respectively
(p ¼ .40) for the endovascular strategy and open repair
groups.
During this period the re-intervention rates for those
treated by EVAR and open repair were 12.5 and 5.0 per 100
person years, respectively (p < .001), but with more re-
interventions for life threatening conditions in those
treated by open repair (p ¼ .041). In the mid-term period,
for patients treated by EVAR, the commonest indication for
a re-intervention was for an endograft related problem
(kinking, migration, or endoleak), which occurred in 21/125
patients (17%): the re-intervention was for secondary
aneurysm rupture in two cases. The patient with type 1A
Table 1. Indications for re-interventions within 90 days of randomisation.
Aneurysm related indication
for 502 repairs with rupture started
Randomised to
EVAR strategy
(n ¼ 259)
Randomised to open repair
(n ¼ 243)
Treated by
EVAR (n ¼ 182)
Treated by open
repair (n ¼ 320)
Access site 4 1 3 2
Abdominal compartment syndrome 7 10 2 15
Bowel ischaemiaa 14 16 5 25
Closure open abdomen 5 5 1 9
Distal aneurysm 1 1 2 0
Endograft kinkingb 2 0 2 0
Endoleakc 3 1 4 0
False aneurysm 1 0 1 0
Graft thrombosis/occlusion 3 0 1 2
Graft infection: aorta 0 2 0 2
Graft infection: femoro-femoral 2 0 2 0
Limb ischaemia 22 13 8 27
Ostomy (stoma) 1 1 1 1
Re-bleeding 3 7 1 9
Other indications
Coronary or brain ischaemia 3 2 2 3
Miscellaneousd 0 3 1 2
Nutritional support 0 1 0 1
Pulmonary embolism 0 2 1 1
Renal failure 0 1 0 1
Tracheostomy for ventilator weaning 5 7 2 10
Upper GI bleed 1 5 1 5
Total re-interventions 77 in 55 patients 78 in 53 patients 40 in 29 patients 115 in 79 patients
Note. There were 27 re-interventions for life threatening indications which occurred in patients randomised to the endovascular aneurysm
repair (EVAR) strategy vs. 41 in those randomised to open repair. Fifteen of these re-interventions for life threatening indications occurred
in patients who received EVAR vs. 53 in those who received open repair. There were two patients in whom two indications were treated
simultaneously, one treated for re-bleeding and bowel ischaemia, and one treated for type 1A endoleak and bowel ischaemia.
GI ¼ gastrointestinal.
a Without abdominal compartment syndrome being diagnosed.
b Prophylactic re-intervention to avoid graft thrombosis or occlusion.
c Two type 1A, two type 2.
d Two perforation sigmoid colon, one pleural effusion.
628 Janet T. Powell et al.endoleak and secondary rupture was treated with a chim-
ney graft to the left renal artery and a proximal cuff,
whereas the patient with type 1B endoleak and secondary
rupture was treated by a right limb extension. Distal
aneurysm (common iliac, internal iliac, or femoral) was the
next most common indication for re-intervention and
occurred in both randomised groups and after treatment by
both EVAR and open repair. Of note further re-interventions
for bowel ischaemia only occurred after patients treated
with open repair, in patients in whom abdominal
compartment syndrome had not been reported earlier.
Graft infection was not common during this period, with the
only two cases occurring after treatment with open repair.
Re-interventions more than 3 years after repair
The data of indications for re-intervention beyond 3 years
are not comprehensive, but available data suggest that
there are continuing serious re-interventions, particularly in
those having received EVAR.
Aortoiliac morphology and re-intervention rate
Previous reports from the IMPROVE trial had not suggested
any important relationships between morphology and re-intervention rate 30 days after randomisation.11 After 3
years, some associations begin to emerge (Table 4). There
were no convincing associations between re-intervention rate
and morphology after treatment by open repair. For those
treated by EVAR, increasing common iliac artery diameterwas
associated with an increased rate of re-interventions, partic-
ularly for arterial related re-interventions, where the rate of
re-intervention increased by almost 50% for each 9 mm in-
crease in common iliac artery diameter.
After 3 years increased aneurysm neck length was asso-
ciated with better survival after both procedures, but
particularly after open repair, mimicking the ﬁndings pre-
viously observed at 30 days (Table S2; see Supplementary
Material).Meta-analysis of amputations within 1 year of rupture
from three randomised trials
Major limb amputation for limb ischaemia is a rare re-
intervention but considered to be the worst re-
intervention by patients. There were eight major amputa-
tions (below knee and more proximal) in the 502 patients
with repair of rupture started in the IMPROVE trial, ﬁve in
those randomised to the endovascular strategy and three in
Table 2. Indications for re-interventions from 3 months to 3 years.
Aneurysm related indication
for 313 repairs with rupture started
who survived beyond 90 days
Randomised to
EVAR strategy
(n ¼ 167)
Randomised
to open repair
(n ¼ 146)
Treated by
EVAR (n ¼ 125)
Treated by open
repair (n ¼ 188)
Access site 3 1 2 2
Bowel ischaemia 2 1 0 3
Distal aneurysm 3 4 3 4
Endograft kinkinga 2 2 4 0
Endograft migration 1 0 1 0
Endoleakb 14 2 16 0
False aneurysm 1 0 1 0
Graft thrombosis/occlusion 6 1 4 3
Graft infection: aorta 0 2 0 2
Graft infection: femoro-femoral 0 0 0 0
Incisional hernia 0 3 0 3
Limb ischaemia 2 2 3 1
Ostomy (stoma) 0 1 0 1
Proximal aneurysm 1 0 1 0
Secondary rupturec 2 0 2 0
Symptomatic adhesions 1 1 0 2
Other indications
Nutritional support 0 1 0 1
Renal failure 1 0 1 0
Total re-interventions 39 in 27 patients 21 in 15 patients 38 in 26 patients 22 in 16 patients
Note. In those randomised to the endovascular aneurysm repair (EVAR) strategy, 17/39 of the re-interventions were for a life threatening
condition vs. 7/21 in those randomised to open repair. In those having undergone EVAR 14/38 of the re-interventions were for life
threatening conditions vs. 10/22 in those having undergone open repair. There were three patients in whom two indications were
treated simultaneously, one for type 1A endoleak and arteriovenous ﬁstula formation for renal failure, one for bowel ischaemia and
incisional hernia, and one for type 1B endoleak and common iliac aneurysm.
a Prophylactic re-intervention to avoid graft thrombosis or occlusion.
b Four type 1A (one also had type 2), two type 1B (one also had type 2), nine type 2 only, and one type 3.
c One patient with a type IA endoleak and renal failure requiring dialysis and one with a type 1B endoleak.
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putations occurred in patients who were treated by open
repair: these all occurred within 12 months of random-
isation and there was one late amputation, after 3 years in
the endovascular strategy group, in a patient treated by
EVAR. The AJAX and ECAR trials also reported major am-
putations within the ﬁrst year after randomisation, at aTable 3. Indications for re-interventions beyond 3 years.
Aneurysm related indication
for 246 repairs with rupture
started who survived beyond
3 years after randomisation
Randomised to
EVAR strategy
(n ¼ 142)
Ran
ope
(n
Access site 1 0
Bowel ischaemia 1 0
Distal aneurysm 3 1
Endoleaka 1 0
Incisional hernia 0 1
Limb ischaemia 1 0
Secondary ruptureb 1 0
Other indications
Renal failure 1 0
Total re-interventions 9 in 7 patients 2 in
Note. In those randomised to the endovascular aneurysm repair (EVA
condition vs. 1/2 in those randomised to open repair. In those ha
threatening conditions vs. 2/5 in those having undergone open repair
a One type 1B.
b Secondary to type 1A endoleak.slightly higher rate than in the IMPROVE trial (three in AJAX
and two in ECAR, all after open repair commenced). Meta-
analysis of amputations to 1 year across the IMPROVE,
AJAX, and ECAR trials by treatment received is shown in
Fig. 1. The risk of amputation was much lower in those
receiving EVAR (OR 0.2, 95% CI 0.05e0.88), with no evi-
dence of heterogeneity.domised to
n repair
¼ 104)
Treated by
EVAR (n ¼ 97)
Treated by open
repair (n ¼ 149)
0 1
0 1
2 2
1 0
0 1
1 0
1 0
1 0
2 patients 6 in 5 patients 5 in 4 patients
R) strategy, 5/9 of the re-interventions were for a life threatening
ving undergone EVAR 4/6 of the re-interventions were for life
.
Table 4. The effect of aortic morphology on re-interventions in the ﬁrst 3 years of follow-up.
Morphological variable Re-interventions Treated by
EVAR (n ¼ 182)
Treated by open
repair (n ¼ 320)
Combined (n ¼ 502)
Time to any AAA related re-intervention
Maximum AAA diameter
(per 17 mm increase)
All 0.97 (0.72e1.32)
p ¼ .86
0.95 (0.77e1.18)
p ¼ .65
0.95 (0.80e1.12)
p ¼ .52
Arterial 1.02 (0.74e1.39)
p ¼ .94
0.85 (0.66e1.09)
p ¼ .21
0.90 (0.74e1.09)
p ¼ .28
Aneurysm neck diameter
at distal renal artery (per
4 mm increase)
All 1.00 (0.77e1.30)
p ¼ .98
1.21 (0.99e1.49)
p ¼ .06
1.15 (0.98e1.35)
p ¼ .09
Arterial 0.98 (0.74e1.29)
p ¼ .88
0.94 (0.72e1.24)
p ¼ .67
0.95 (0.78e1.16)
p ¼ .63
Aneurysm neck length
(per 16 mm increase)
All 0.80 (0.58e1.10)
p ¼ .16
0.89 (0.72e1.10)
p ¼ .28
0.87 (0.73e1.03)
p ¼ .12
Arterial 0.74 (0.53e1.04)
p ¼ .08
0.89 (0.69e1.16)
p ¼ .40
0.84 (0.69e1.03)
p ¼ .09
Neck conicality (per 1.6%,
per mm length, change
increase)
All 0.72 (0.45e1.15)
p ¼ .17
0.91 (0.74e1.11)
p ¼ .36
0.87 (0.72e1.06)
p ¼ .16
Arterial 0.65 (0.39e1.10)
p ¼ .11
1.07 (0.87e1.31)
p ¼ .52
0.97 (0.77e1.22)
p ¼ .80
Proximal aneurysm neck
(a) angle (per 20
increase)
All 1.01 (0.77e1.31)
p ¼ .96
1.05 (0.89e1.24)
p ¼ .56
1.04 (0.90e1.19)
p ¼ .62
Arterial 0.96 (0.72e1.29)
p ¼ .79
0.90 (0.70e1.16)
p ¼ .42
0.93 (0.77e1.12)
p ¼ .42
Maximum common iliac
diameter (per 9 mm
increase)a
All 1.32 (1.01e1.72)
p ¼ .041
1.06 (0.91e1.24)
p ¼ .45
1.11 (0.98e1.26)
p ¼ .11
Arterial 1.48 (1.13e1.93)
p ¼ .004
1.11 (0.92e1.35)
p ¼ .28
1.20 (1.04e1.39)
p ¼ .013
Note. Data are hazard ratio (95% CI). Aortic morphology and the risk of experiencing any re-intervention within 3 years (with multiple
imputation for missing variables). Multivariate model adjusted for all six morphological variables in addition to age, sex, Hardman
index, lowest recorded systolic blood pressure, and randomised group. Hazard ratios are presented per SD increase of morphological
parameter. These analyses are restricted to 502 patients with conﬁrmed rupture who received an operation by treatment received
(endovascular aneurysm repair [EVAR], open or EVAR converted to open). All aneurysm related re-interventions (and only arterial re-
interventions) are considered separately.
a Excluding eight patients with a ruptured common iliac aneurysm.
Figure 1. Meta-analysis of three ruptured abdominal aortic aneurysm trials for amputations within the ﬁrst year of randomisation, by
treatment received. Note. CI ¼ conﬁdence interval.
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This report describes the reasons underlying the high rates of
re-intervention reported after repair of ruptured AAA, de-
tailing the re-interventions both by randomised group, as
reported previously,4 and by treatment received. Overall the
percentage (w28%) of patients requiring one or more re-
interventions by 3 years is twice that reported from the
Medicare database.2 Although the rates in the acute period of
care (0e90 days) are highest, there is a signiﬁcant rate of mid-
term re-interventions in both the endovascular strategy and
open repair groups, with about one third of these re-
interventions needed for a life threatening condition. These
mid-term re-intervention rates are over twice those reported
after elective repair of large AAA.1 It is also clear that mid-
term re-intervention is needed for endograft related compli-
cations for about one in six patients after EVARand that bowel
ischaemia is amore important problemafter open repair, with
further mid-term re-interventions required for this condition.
The present analysis indicates that the rate of arterial re-
interventions is associated with increasing common iliac di-
ameters at presentation, perhaps indicative ofmore extensive
aneurysmal disease. The re-intervention most feared by pa-
tients is major limb amputation; fortunately, this is a rare
event but individual patient data meta-analysis of the three
recent European randomised trials for the management of
ruptured AAA shows that amputation is ﬁve times more
frequent after open repair than EVAR.
The complications and re-interventions required during the
primary admission for AAA rupture have been described in the
largeMedicare dataset.19 The only previous detailed reporting
of midterm re-interventions comes from the Amsterdam
cohort, which followed 467 patients (130 treated by EVAR, 337
by open repair).3 The prospective data from the IMPROVE trial
provide more cases with EVAR treated predominantly with
bifurcated endografts, compared with the preferred use of
aorto-uni-iliac endografts in the AJAX trial and Amsterdam
study.5 The ﬁnding from the Amsterdam cohort that graft
infection was the commonest reason for mid-term re-inter-
vention cannot be conﬁrmed. Interestingly, the only two cases
of graft infection after EVAR came in the acute period andwere
in the femoro-femoral crossover graft of patients who had
been treated with an aorto-uni-iliac endograft. In the acute
period abdominal compartment syndrome, bowel ischaemia
and limb ischaemia were all more common after open repair.
Amputationwasmuchmore common after treatment by open
repair, although because this is a rare event it needed the
combined data from three trials to show this. Taken together
this information might suggest the direction of future quality
improvement programmes, with stricter adherence to pro-
tocols to detect abdominal compartment syndrome and bowel
ischaemia, and new protocols for early post-operative imaging
to identify limb ischaemia and potential future problems from
distal aneurysms: these latter protocols are a topic for future
research and evaluation.
In the mid-term the commonest reason for re-
intervention was endoleak, with about half of these being
type II endoleaks: perhaps there is more enthusiasm fortreating type II endoleaks after rupture than after elective
repair. The next most common indication for re-intervention
was distal aneurysm (in the iliac or common femoral ar-
teries). This is likely to have contributed to the observation
that increasing common iliac artery diameter was associated
with an increasing rate of arterial re-interventions. There are
several potential reasons for this, including focal iliac dila-
tation not being recognised before repair and the accep-
tance of a less durable seal in the common iliac artery after
EVAR, to avoid internal iliac embolisation, which worsens
pelvic ischaemia and prolongs the procedure. There was no
other convincing evidence that other morphological pa-
rameters, including maximum aortic diameter, inﬂuenced
the mid-term re-intervention rate. There were two cases of
secondary rupture, both after EVAR, but neither was fatal.
The present study has some limitations. The most
important of these is that data on re-interventions for the
IMPROVE trial were collected from an economic perspective,
with the reasons for re-intervention being collected as free
text, rather than according to reporting standards. There was
no separate collection of data for complications, which may
not have been treated, unless they required a hospital
admission. The grading of re-interventions as life threatening
or not was undertaken retrospectively, following a survey of
trial investigators and not included in the case record forms.
Also, although the 3 month CT scans were collected in the
core laboratory, there were no resources for detailed
assessment of whether endograft under sizing was respon-
sible, at least in part, for arterial re-interventions after EVAR.
In summary, this report raises two important matters.
Firstly, the continuing need for mid-term re-interventions for
life threatening conditions after both EVAR andopen repair, at
more than twice the rates after elective repair, might suggest
that surveillance policies after rupture need to be more
strictly enforced and more intensive than those offered after
elective repair, particularly for those with open repair and/or
greater common iliac diameters. Secondly, clinicians and pa-
tients view the impact of re-interventions rather differently
and perhaps patient focused outcomes should be included in
routine reporting metrics following rupture.
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